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Background: Acinetobacter baumannii is one of the most important pathogens capable of 
colonization in burn patients, leading to drug-resistant wound infections. This study evalu-
ated the distribution of the AdeABC efflux system genes and their relationship to ciproflox-
acin resistance in A. baumannii isolates collected from burn patients.
Methods: A total of 68 A. baumannii clinical strains were isolated from patients hospital-
ized in Motahari Burns Center in Tehran, Iran. Ciprofloxacin susceptibility was tested by 
the disk diffusion and agar dilution methods. PCR amplification of the adeRS-adeB drug 
efflux genes was performed for all resistant and susceptible isolates. To assess the role of 
the drug efflux pump in ciproﬂoxacin susceptibility, carbonyl cyanide 3-chlorophenylhy-
drazone (CCCP) was used as an efflux pump inhibitor (EPI).
Results: Approximately 95.6% of the Acinetobacter isolates were resistant to ciprofloxacin, 
with minimum inhibitory concentration (MIC) values ranging from 4 to ≥128 µg/mL. The 
susceptibility of 86.1% of the resistant isolates increased by factors of 2 to 64 in the pres-
ence of CCCP. All resistant isolates were positive for the adeRS-adeB genes, and 73.2% of 
them had mutations in the AdeRS regulatory system.
Conclusions: The results showed that AdeABC genes are common in A. baumannii, which 
might be associated with ciprofloxacin non-susceptibility, as indicated by the observed link-
age to the presence of the genes essential for the activity of the AdeABC, several single 
mutations occurring in the adeRS regulatory system, and an increase of ciprofloxacin sus-
ceptibility in the presence of a CCCP EPI.
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INTRODUCTION
Burn injuries are one of the most important health problems in 
many countries [1, 2]. Organisms associated with nosocomial 
infections in burn patients include normal flora from exogenous 
sources in the environment and from healthcare personnel. Cur-
rently, Acinetobacter baumannii and Pseudomonas aeruginosa 
are two of the most common causes of burn wound infections 
[3, 4]. Of great concern is the spread of A. baumannii strains 
because of their ability to develop resistance to multiple com-
monly used antibiotics, including fluoroquinolones. Multidrug 
resistance is often responsible for the failure of antibiotic therapy 
[5, 6]. Fluoroquinolones, such as ciprofloxacin (CIP), are very 
potent antimicrobials that are used as first line antibiotics against 
A. baumannii infections [7]. Resistance to fluoroquinolones is 
mediated primarily by spontaneous mutations in their targets, 
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DNA gyrase and topoisomerase IV [7, 8]. A secondary mecha-
nism responsible for fluoroquinolone resistance is reduction in 
drug accumulation due to overexpression of active efflux pumps 
[7, 9, 10]. In an energy dependent manner, bacterial drug efflux 
systems pump out a wide range of antibacterial agents, includ-
ing antibiotics, biocides, and solvents, without alteration or deg-
radation. In such conditions, the intracellular antibiotic concen-
tration is decreased, and bacteria become less susceptible to 
the compound [10, 11].
 Recently, the role of the AdeABC efflux pump in Acinetobacter 
drug resistance was described [12, 13]. This efflux pump be-
longs to the resistance-nodulation-cell division (RND) family and 
has a three-component structure: AdeA is the membrane fusion 
protein, AdeB is the multidrug transporter, and AdeC is the outer 
membrane protein. The adeABC operon is strongly regulated by 
a two-component system (AdeR-AdeS): AdeS is a sensor kinase 
and AdeR is a response regulator. Overexpression of the Ade-
ABC efflux pump can be caused either by the point mutations in 
AdeRS or by the insertion sequence (IS) Aba-1 insertion up-
stream of the adeABC operon [12-14]. Single point mutations in 
adeR (Pro116Leu) and adeS (Thr153Met) are known to be as-
sociated with AdeABC overexpression [13], and, subsequently, 
with resistance to several antibiotics, including aminoglycosides, 
fluoroquinolones, tetracyclines, chloramphenicol, and β-lactams 
[12, 13]. However, these mutations have not been observed in a 
small number of clinical isolates with increased levels of expres-
sion of AdeABC [15, 16].
 Several studies in Iran found increased fluoroquinolone resis-
tance among clinical isolates of A. baumannii and a spread of 
drug-resistant strains among burn patients in Tehran hospitals. 
However, the efflux pumps, including those of the RND family 
that produce multidrug resistance in A. baumannii isolates have 
not been investigated. In this study, we assessed the association 
of the AdeABC efflux genes with CIP non-susceptibility in A. 
baumannii isolates.
METHODS
1. Study population and bacterial isolates
Sixty-eight clinical isolates of A. baumannii recovered from pa-
tients admitted to the burn unit of Motahari Hospital in Tehran, 
Iran during the latter part of 2011 were selected for this study. 
After the burn wound exudates were sampled for clinical speci-
mens, they were examined microbiologically. Bacterial isolates 
were identified as A. baumannii by using standard biochemical 
procedures according to the criteria of Bouvet and Grimont [17]. 
Identifications were confirmed by PCR amplification of the in-
trinsic blaOXA-51-like gene [18, 19].
2. Antibiotic susceptibility testing
Antimicrobial susceptibility tests were performed by using the 
Kirby-Bauer disk diffusion agar method on Mueller-Hinton (M-
H) agar plates (Merck; Darmstadt, Germany) to designate iso-
lates as either ciprofloxacin-resistant A. baumannii (CRAB) or 
ciprofloxacin-susceptible A. baumannii (CSAB). The minimum 
inhibitory concentration (MIC) of CIP against CRAB isolates was 
evaluated by using the agar dilution technique. Both of these 
methods were performed according tothe CLSI guidelines [20]. 
Pseudomonas aeruginosa ATCC 27853 was used as the control 
strain in susceptibility testing.
3. PCR and nucleotide sequencing
The presence of one structural (adeB) and two regulatory (adeR 
and adeS) genes of the AdeABC system were investigated by 
PCR in CRAB and CSAB isolates. The three pairs of oligonucle-
otide primers were: adeB primer, adeB-F (5’-TTAACGATAGC-
GTTGTAACC-3’) and adeB-R (5’-TGAGCAGACAATGGAATAGT-
3’);adeR primer, adeR-F (5’-ACTACGATATTGGCGACATT-3’) and 
adeR-R (5’-GCGTCAGATTAAGCAAGATT-3’); and adeS primer, 
adeS-F (5’-TTGGTTAGCCACTGTTATCT-3’) and adeS-R (5’- 
AGTGGACGTTAGGTCAAGTT-3’). Genomic DNA was extracted 
from bacterial colonies by using the Genomic DNA Purification 
Kit (Fermentase; Vilnius, Lithuania) according to the manufac-
turer’s instructions. Each PCR reaction mixture contained 10 µL 
of 2× Master Mix (Ampliqon; Odense, Denmark), including 1× 
PCR buffer, 1.5 mmol/L MgCl2, 0.15 mmol/L dNTP, 1.25 IU 
TaqDNA polymerase, 0.5 µL of 0.8 µM of each primer, 1 µL of 
template DNA (0.5 µg), and sterile distilled water up to 25 µL. 
DNA amplification was carried out in a Mastercycler gradient 
(Eppendorf; Hamburg, Germany) instrument with initial dena-
turation at 94°C for 5 min followed by 30 cycles of amplification 
(denaturation at 94°C for 1 min, then annealing at 57°C for 1 
min, and extension at 72°C for 1 min), ending with a final exten-
sion at 72°C for 5 min. The amplified products were resolved by 
electrophoresis on 2% agarose gels stained with ethidium bro-
mide. Sequencing of the PCR products of the adeR and adeS 
genes in 56 CRAB and CSAB isolates with or without active ef-
flux pumps, respectively, was performed by using an ABI 
3730XL DNA Analyzer (Applied Biosystem Inc., Forster City, CA, 
USA). The sequences were compared with GenBank genes by 
using the BLAST tool available on the National Center for Bio-
technology Information (NCBI) website (http://www.ncbi.nlm.
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nih.gov/BLAST/).
4. Treatment of the efflux pump inhibitor
A functional efflux system was assessed by measuring the MICs 
for CIP before and after exposure to the efflux pump inhibitor 
(EPI), carbonyl cyanide 3-chlorophenylhydrazone (CCCP) 
(Sigma-Aldrich, Dorset, United Kingdom). This compound is an 
uncoupler of oxidative phosphorylation, which disrupts the pro-
ton gradient of the membranes that is required for activity of 
RND-type pumps [15]. Therefore, addition of CCCP to M-H 
agar plates leads to increased accumulation of antibiotic and, 
consequently, reduction of the MIC in isolates that carry active 
efflux pumps. Briefly, CCCP was added to each of the M-H agar 
plates containing 0.5-128 µg/mL CIP at a final concentration of 
25 µg/mL [21]. The MIC of CIP was determined for all CRAB 
and CSAB isolates against the A. baumannii ATCC 19606 strain. 
The plate with CCCP that did not contain antibiotic was used as 
a control. The effects ofthe EPI were determined by detecting a 
4-fold or greater increase in susceptibility after incorporation of 
CCCP [21].
RESULTS
1. Bacterial isolates and ciprofloxacin resistance
During the 6-month period, 68 isolates of A. baumannii were 
collected from hospitalized burn patients. Susceptibility testing 
using the disk diffusion method determined that 95.6% (65/68) 
of isolates showed resistance to CIP. According to the estab-
lished breakpoint values recommended by the CLSI [20], A. 
baumannii isolates with MIC ≥4 µg/mL were considered CIP re-
sistant. As shown in Table 1, the MIC of CIP in 6.1% (4/65) and 
53.8% (35/65) of CRAB isolates was 4 µg/mL and ≥128 µg/
mL, respectively, whereas a significant proportion of isolates 
(43%) had an MIC value equal to 128 µg/mL.
2. Inhibitory effects of CCCP on the efflux system
M-H agar plates containing 25 µg/mL CCCP were used to verify 
the efflux pump effect on CIP resistance in the 65 CRAB iso-
lates that were found to possess adeRS-adeB genes. The addi-
tion of the EPI produced a 2- to 64-fold reduction of resistance 
in 86.2% (56/65) of the isolates that were resistant to CIP (Table 
1). CCCP had no effect on the MIC of CIP for the A. baumannii 
ATCC 19606 strain. All bacteria grew well in M-H agar plates 
with CCCP but without CIP, indicating that 25 µg/mL CCCP had 
no intrinsic antibacterial activity. Interestingly, 3 CSAB isolates 
had no active efflux pump, as determined by the absence of 
changes in MIC after adding CCCP, despite the fact that they 
possessed relevant adeABC genes according to PCR results.
3.  PCR detection and nucleotide sequencing of the AdeABC 
efflux system
Specific PCR analysis demonstrated that all 65 CRAB and 3 
CSAB isolates harbored the chromosomal adeB, adeR, and 
adeS genes, concomitantly. Amplification of transporter adeB, 
response regulator adeR, and its cognate kinase adeS genes 
produced bands of 541, 447, and 544 bp, respectively. To de-
termine whether the CIP resistance in the 56 isolates harboring 
an active efflux pump was due to alterations in the regulatory 
region of the adeABC operon, we sequenced both amplified 
adeR and adeS genes. The nucleotide sequence data of the 
PCR productsshowed that 73.2% (41/56) of sequenced isolates 
had several point mutations in the AdeRS regulatory system. 
Point mutations in adeR (Pro116Leu) and adeS (Thr153Met) 
known to cause AdeABC overexpression were not identified in 
Table 1. Amino acid substitutions in the adeR and adeS gene products in 65 CRAB isolates with or without changes in ciprofloxacin MIC in 
the presence of CCCP
N of isolates
   (%)
MIC of CIP
(µg/mL)
MIC ranges of
CIP+CCCP (µg/mL)
Fold reduction in MIC of 
CIP+CCCP
     Changes in the AdeR
     amino acid sequence
Changes in the AdeS
amino acid sequence
4 (6.1) 4 1-2 2 to 4 p.His158Leu, p.Pro116Ser p.Ala94Val, p.Lys84Glu
3 (4.6) 8 1-4 2 to 8 p.Leu142Ile, p.Val120Ile p.Ala97Ser, p.Lys84Glu
1 (1.5) 16 8 2 p.Pro116Ser, p.Ala136Val p.Ala97Ser
7 (10.7) 32 4-32 0 to 8 p.His158Leu, p.Met88Leu p.Gly103Asp, p.Leu105Phe
15 (23) 64 1-64 0 to 64 p.His158Leu, p.Pro116Ser, p.Gly36Val p.Ala94Val, p.Gly103Asp
28 (43) 128 32-128 0 to 4 p.Ala136Val, p.Val120Ile p.Gly103Asp
7 (10.7) >128 32-128 >2 to >4 p.His158Leu, p.Met88Leu p.Gly103Asp, p.Lys84Glu
Abbreviations: CRAB, ciprofloxacin-resistant A. baumannii; MIC, minimum inhibitory concentration; CIP, ciprofloxacin; CCCP, carbonyl cyanide 3-chloro-
phenylhydrazone.
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any isolates [13]. In addition, the isolates for which the MIC of 
CIP was higher (32 to ≥128 µg/mL) generally had more muta-
tions in their adeRS genes. However, the sequencing results of 
PCR products demonstrated that the 3 CSAB isolates had no 
changes in adeR and adeS regulatory genes.
DISCUSSION
Prolonged patient stays in burn wards and the major threat of 
the spread of multidrug-resistant bacterial pathogens causing 
healthcare-associated infections are major concerns of infec-
tious disease specialists [1, 22, 23]. A. baumannii is an impor-
tant human pathogen that is able to survive on inanimate and 
dry surfaces for prolonged periods, and is isolated with increas-
ing frequency from biological materials of burn patients. In re-
cent years, this organism’s resistance to various antibiotics, 
such as fluoroquinolones, has become a critical concern world-
wide, including in Iran. In our study, 95.6% of A. baumannii 
isolates were resistant to CIP, similar to reports from other stud-
ies [24-27]. However, the resistance rate observed in our inves-
tigation was higher than those found in the United Kingdom and 
China (50.9% and 61.2%, respectively) [6, 28]. This discrep-
ancy could be due to differences in the quality control of antimi-
crobial susceptibility tests, patterns of antibiotic usage, environ-
mental factors, and the geographical distribution of resistance in 
various countries. Most of the 65 resistant strains showed high 
levels of resistance to CIP, whereby the MIC range in 12.3% and 
87.7% of these isolates was 4-16 µg/mL and 32 to more than 
128 µg/mL, respectively. These results are consistent with the 
findings by Valentine et al. [5] where the MIC range of CIP of 
their isolates was 16-256 µg/mL [5]. Therefore, according to our 
results and those of other studies, the rate of resistance to CIP 
among A. baumannii strains has increased in many countries.
 Various studies on A. baumannii and a number of other clini-
cally important bacteria have demonstrated that efflux pumps 
play an important role in resistance to antibiotics, including fluo-
roquinolones [7, 29]. The 65 CRAB isolates evaluated in our 
study couldbe classified into two main groups: 1) positive for all 
three adeRS-adeB genes, with a conversed CIP resistance pat-
tern in the presence of CCCP (86.2% of CRAB isolates), and 2) 
positive for all three adeRS-adeB genes, but no changes in MIC 
observed when an EPI was added to each M-H agar plate 
(13.8% of CRAB isolates). Consistent with the results by Lin et 
al. [30], we found that the MIC of CIP decreased in most CRAB 
isolates in the presence of CCCP, mainly 2- to 4-folds. As a four-
fold or greater difference in susceptibility was considered signifi-
cant, our study also showed that the MIC for 30 of the 65 resis-
tant isolates (46.1%) was reduced significantly by 4- to 64-folds 
when the EPI was added. These results verified that enhanced 
efflux pumps are involved in resistance to fluoroquinolones in A. 
baumannii isolates. However, the failure of CCCP to affect the 
MICs of CRAB isolates in the second group, despite the pres-
ence of the AdeABC system, suggests that the efflux pump is 
not an important contributor to overt CIP resistance in some of 
our isolates. Instead, mutations in the GyrA and ParC subunits 
or other molecular mechanisms might be involved.
 According to the nucleotide sequence data of the adeR and 
adeS genes, the first group of our CRAB isolates could be sub-
divided into two groups: a significant percentage (73.2%) of se-
quenced isolates that had several point mutations leading to 
amino acid substitutions in the AdeR and AdeS sequences, and 
a small number (26.8%) of isolates with no changes. Many of 
these mutations, including Leu142Ile and Val120Ile in adeR 
and Ala94Val and Phe214Leu in adeS, have been previously re-
ported in multi-drug resistant isolates of A. baumannii [15, 31, 
32]. In regard to their importance to drug resistance, the Ala-
94Val substitution is located within the histidine kinase, adenylyl 
cyclase, methyl-accepting chemotaxis protein and phosphatase 
(HAMP) domain of AdeS. The HAMP domain is thought to be 
involved in transmembrane signal transduction, and mutations 
in this domain have been associated with constitutive pheno-
types [33, 34]. Therefore, both the conversion of the CIP resis-
tance pattern in the presence of an EPI in all mutated isolates 
and the presence of changes within the adeRS operon of iso-
lates that showed higher resistance suggest the possibility that 
multiple point mutations contribute to AdeABC pump overex-
pression and CIP-resistant phenotypes.
 Although the presence of the AdeABC efflux pump was 
shown by PCR and verified by decreased CIP resistance in a 
phenotypic assay, we found no adeRS mutations in 26.8% of 
the sequenced isolates, a result that is consistent with the study 
by Peleg et al. [15]. The absence of mutations in these isolates, 
despite decreased MICs in the presence of CCCP, indicates ei-
ther that other mechanisms (e.g., the insertion element ISAba1) 
might be responsible for increased pump activity or that other 
efflux systems are involved in CIP resistance.
 In conclusion, our study represents the first attempt to dem-
onstrate an increased rate of CRAB isolates as nosocomial 
pathogens and distributed AdeABC pumps as a mechanism as-
sociated with CIP resistance in the majority of the A. baumannii 
strains found in a clinical setting. Ongoing efforts should be 
aimed at detecting these bacteria and their resistance mecha-
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nisms, controlling their related infections, and employing new 
antimicrobials with activities against such problematic organ-
isms. Our study may be limited by the facts that our experi-
ments used bacterial isolates collected from a single clinical 
center and the expression level of adeB was not measured. Fur-
ther studies are required to elucidate the precise mechanism 
leading to the enhanced pump activity and to determine the ef-
fect of ISAba1 insertion on the regulation of adeABC expression 
and drug resistance.
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